Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Levitam 500 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Levitam 500

Approved

STANDARD

Levitam 500

Zhejiang Jingxin Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d435c0d7fc9057b7
Company: Zhejiang Jingxin Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: d435c0d7fc9057b7
Drug Approval Philippines Name: Levitam 500
Product Name: Levitam 500
Registration Number: DRP-13585-01
Brand Name: Levitam 500
Generic Name: Levetiracetam
Dosage Form: Film-Coated Tablet
Dosage Strength: 500 mg
Manufacturer: Zhejiang Jingxin Pharmaceutical Co., Ltd.
Importer: Medinova Pharmaceutical Inc.
Distributor: GA2 Pharmaceutical Inc.
Company Detail Path: /organization/zhejiang-jingxin-pharmachutical-co-ltd
Issuance Date: 29 March 2024
Expiry Date: 14 March 2028
Pharmacologic Category: Antiepileptic
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d435c0d7fc9057b7

Type

Standard

Back to Philippines FDA Approvals